| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.49B | 17.61B | 14.23B | 13.98B | 12.72B | 13.05B |
| Gross Profit | 13.49B | 14.17B | 13.62B | 13.95B | 12.69B | 13.02B |
| EBITDA | 3.05B | 2.98B | 2.10B | 2.43B | 2.59B | 2.40B |
| Net Income | 1.16B | 1.69B | 1.07B | 1.38B | 1.53B | 1.34B |
Balance Sheet | ||||||
| Total Assets | 1.05T | 1.02T | 1.01T | 1.01T | 968.13B | 1.03T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 76.54B | 63.41B | 84.02B | 43.69B | 167.68B |
| Total Debt | 107.38B | 59.57B | 79.20B | 34.44B | 8.86B | 157.91B |
| Total Liabilities | 1.01T | 990.93B | 974.24B | 973.26B | 929.39B | 987.05B |
| Stockholders Equity | 36.75B | 33.50B | 35.38B | 39.44B | 38.74B | 39.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 26.65B | 25.75B | 24.84B | -111.45B | 10.89B |
| Operating Cash Flow | 0.00 | 27.10B | 26.16B | 25.61B | -110.90B | 11.06B |
| Investing Cash Flow | 0.00 | -16.93B | -30.36B | -2.09B | -11.28B | -916.00M |
| Financing Cash Flow | 0.00 | -5.21B | -534.00M | 20.40B | -475.00M | -474.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥196.10B | 13.06 | ― | 2.23% | 31.23% | 66.11% | |
71 Outperform | ¥108.97B | 11.29 | ― | 3.35% | 26.92% | 35.22% | |
68 Neutral | ¥12.87B | 7.27 | ― | 3.74% | 15.32% | 26.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥93.31B | 11.37 | ― | 2.89% | 23.58% | 50.43% | |
62 Neutral | ¥13.66B | 7.95 | ― | 3.58% | 18.86% | 59.05% | |
52 Neutral | ¥12.87B | 17.29 | ― | 1.89% | 17.42% | ― |